News
Article
Author(s):
Travelers face rising infectious disease risks, including measles, chikungunya, chagas disease, and others.
As international travel increases, so does the risk of exposure to infectious diseases. Global mobility, climate change, and lapses in vaccination coverage have fueled the resurgence and spread of illnesses such as measles, chikungunya, and chagas disease.
For travelers, vaccination remains one of the most effective ways to reduce risk, both for personal protection and to prevent the importation of infectious diseases across borders.
Miniature traveler looking for vaccine | Image Credit: © Yuan - stock.adobe.com
Several infectious diseases continue to circulate globally, presenting risks to unvaccinated or underprepared travelers. Some, like measles, are resurgent even in countries with historically strong immunization programs. For example, the US is experiencing the largest measles outbreak since 2000, totaling over 1400 cases. According to global health reporting, surges in measles cases are present in every region on the planet including Europe, Africa, Asia, Central and South America, and Canada—a result of declining immunization rates.1-6
As global temperatures rise, other diseases spread by insects are becoming more prevalent in regions where they previously were not. For example, rising temperature create the ideal environment for mosquitos, who can carry a host of diseases. Most notable, chikungunya is spreading rapidly in China, Latin America, and Europe—areas which have not seen such outbreaks in the past.7
Chagas disease, originally endemic to Mexico and Central and South America, is now regularly circulating in the US, according to a report published by the CDC. California is experiencing the highest rate of cases at anywhere between 70,000 and 100,000. Human cases have also been reported in Arizona, Texas, Louisiana, Missouri, Tennessee, and Arkansas. However, the risk is widespread with kissing bugs found across all states.8,9
The CDC also reports increasing rabies cases in the US driven by habitat loss and lack of vaccination. As natural habitats shrink, contact between humans and wild animals grows more frequent, increasing the risk of diseases such as rabies. As of September 2025, the CDC reported 6 deaths from rabies in the US, marking the highest number in years. These cases were connected to exposure to rabid animals including raccoons, skunks, and gray foxes. Affected areas including Nassau County, New York; Cape Cod, Massachusetts; and parts of Alaska, Arizona, California, Indiana, Kentucky, Maine, North Carolina, Oregon, and Vermont.10
“We are currently tracking 15 different likely outbreaks,” Ryan Wallace, MD, leader of the rabies team at the Centers for Disease Control and Prevention, told NBC News.10
For measles, the CDC recommends that all travelers are fully vaccinated with the measles, mumps, and rubella (MMR) vaccine. Children should receive 2 doses, the first at 12 to 15 months of age and the second at 4 to 6 years. Adults without evidence of immunity should also be vaccinated, particularly those at higher risk such as international travelers, health care workers, and college students. Infants as young as 6 months who are traveling internationally should receive a dose before departure, although this dose does not count toward the routine series. Vaccination should be done about 2 weeks prior to travel.11,12
Chikungunya vaccines are available in the United States, but the live-attenuated vaccine Ixchiq (Valneva) has had its US biologics license suspended by the FDA. As of August 22, 2025, use of Ixchiq was halted after reports of serious adverse events, including hospitalizations, neurologic issues, and at least 1 death from vaccine strain encephalitis. The remaining vaccine, Vimkunya (Bavarian Nordic), is a virus-like particle vaccine approved for individuals 12 years and older and continues to be available.13,14
The CDC recommends vaccination for travelers going to areas with current chikungunya outbreaks, and for long-term stays or moves to regions where the virus is endemic. Special caution is advised especially for older adults (initially ≥60 or ≥65), those with chronic medical conditions, immunocompromised people, and pregnant or breastfeeding individuals.13,14
For rabies, the CDC advises pre-exposure prophylaxis (PrEP) for travelers to countries where rabies is common and where timely access to post-exposure treatment may be limited. In 2022, the Advisory Committee on Immunization Practices updated recommendations to a 2-dose vaccine series given on days 0 and 7, replacing the previous 3-dose schedule. Pre-exposure vaccination is also recommended for veterinarians, animal handlers, and other high-risk groups. In the event of an exposure, those who are unvaccinated require immediate wound care, rabies immune globulin, and a vaccine series, whereas vaccinated individuals receive only a reduced vaccine series without immune globulin.15
As of 2025, Chagas disease has no vaccine or preventive drug available. The CDC stresses the importance of preventive measures such as avoiding insect bites from kissing bugs, using bed nets, and improving housing conditions in endemic areas. Blood screening and vector control efforts also remain critical to reducing transmission.9
Several other vaccines are important to consider for international travelers. Yellow fever vaccination is required for entry into certain countries in Africa and South America and remains essential protection against outbreaks.16
Japanese encephalitis vaccination is recommended for travelers spending extended periods in rural areas of Asia, particularly during transmission seasons.17
Typhoid vaccination is advised for those traveling to areas with poor sanitation or where the disease is common, such as South Asia, parts of Africa, and Latin America.18
Polio remains a risk in parts of the world and outbreaks have been announced in Papau New Guinea and areas of the Middle East, particularly Gaza.19,20
Finally, both hepatitis A and B are widely circulating globally, and vaccination is strongly recommended for travelers, particularly given the ease of transmission through food, water, blood, and sexual contact.21
As frontline health care providers, pharmacists play a critical role in ensuring travelers are protected against infectious diseases. By counseling patients on recommended vaccines, verifying immunization status, and providing guidance on preventive measures, pharmacists help reduce individual risk and curb the international spread of diseases. Staying up to date on CDC guidelines and emerging outbreaks helps pharmacists offer timely, evidence-based recommendations that safeguard both travelers and the communities they return to.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.